Prevalence and Clinical Implications of COVID-19 Myocarditis

Card Electrophysiol Clin. 2022 Mar;14(1):53-62. doi: 10.1016/j.ccep.2021.11.001. Epub 2021 Nov 9.

Abstract

The clinical manifestations of COVID-19 are widely variable and may involve several districts. Although the clinical course is mostly characterized by respiratory involvement, up to 30% of hospitalized patients have evidence of myocardial injury due to acute coronary syndrome, cardiac arrhythmias, myocarditis, and cardiogenic shock. In particular, myocarditis is a well-recognized severe complication of COVID-19 and is associated with fulminant cardiogenic shock and sudden cardiac death. In this article, the authors aim to present a comprehensive review about COVID-19-related myocarditis, including clinical characteristics, diagnostic workup, and management.

Keywords: Arrhythmias; COVID-19; Myocardial damage; Myocarditis; SARS-CoV-2; Vascular damage.

Publication types

  • Review

MeSH terms

  • Arrhythmias, Cardiac / complications
  • COVID-19* / complications
  • Humans
  • Myocarditis* / complications
  • Myocarditis* / diagnosis
  • Myocarditis* / epidemiology
  • Prevalence
  • SARS-CoV-2